|
1
|
Watanabe K, Sukumaran V, Veeraveedu PT,
Thandavarayan RA, Gurusamy N, Ma M, Arozal W, Sari FR, Lakshmanan
AP, Arumugam S, et al: Regulation of inflammation and myocardial
fibrosis in experimental autoimmune myocarditis. Inflamm Allergy
Drug Targets. 10:218–225. 2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Blyszczuk P, Muller-Edenborn B, Valenta T,
Osto E, Stellato M, Behnke S, Glatz K, Basler K, Luscher TF,
Distler O, et al: Transforming growth factor-β-dependent Wnt
secretion controls myofibroblast formation and myocardial fibrosis
progression in experimental autoimmune myocarditis. Eur Heart J.
38:1413–1425. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Siwik DA, Chang DL and Colucci WS:
Interleukin-1beta and tumor necrosis factor-alpha decrease collagen
synthesis and increase matrix metalloproteinase activity in cardiac
fibroblasts in vitro. Circ Res. 86:1259–1265. 2000.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ono K, Matsumori A, Shioi T, Furukawa Y
and Sasayama S: Cytokine gene expression after myocardial
infarction in rat hearts: Possible implication in left ventricular
remodeling. Circulation. 98:149–156. 1998.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cardona A, Baker P, Kahwash R, Smart S,
Phay JE, Basso C and Raman SV: Evidence of aldosterone synthesis in
human myocardium in acute myocarditis. Int J Cardiol. 275:114–119.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xiao J, Shimada M, Liu W, Hu D and
Matsumori A: Anti-inflammatory effects of eplerenone on viral
myocarditis. Eur J Heart Fail. 11:349–353. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Leader CJ, Moharram M, Coffey S, Sammut
IA, Wilkins GW and Walker RJ: Myocardial global longitudinal
strain: An early indicator of cardiac interstitial fibrosis
modified by spironolactone, in a unique hypertensive rat model.
PLoS One. 14(e0220837)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cohen JB, Schrauben SJ, Zhao L, Basso MD,
Cvijic ME, Li Z, Yarde M, Wang Z, Bhattacharya PT, Chirinos DA, et
al: Clinical phenogroups in heart failure with preserved ejection
fraction: Detailed phenotypes, prognosis, and response to
spironolactone. JACC Heart Fail. 8:172–184. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tanaka H, Sagisaka A, Suzuki N and
Yamakawa M: Bombyx mori E26 transformation-specific 2 (BmEts2), an
Ets family protein, represses Bombyx mori Rels (BmRels)-mediated
promoter activation of antimicrobial peptide genes in the silkworm
Bombyx mori. Insect Mol Biol. 25:566–579. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gum R, Lengyel E, Juarez J, Chen JH, Sato
H, Seiki M and Boyd D: Stimulation of 92-kDa gelatinase B promoter
activity by ras is mitogen-activated protein kinase kinase
1-independent and requires multiple transcription factor binding
sites including closely spaced PEA3/ets and AP-1 sequences. J Biol
Chem. 271:10672–10680. 1996.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nakamura Y, Esnault S, Maeda T, Kelly EA,
Malter JS and Jarjour NN: Ets-1 regulates TNF-alpha-induced matrix
metalloproteinase-9 and tenascin expression in primary bronchial
fibroblasts. J Immunol. 172:1945–1952. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cihakova D, Sharma RB, Fairweather D,
Afanasyeva M and Rose NR: Animal models for autoimmune myocarditis
and autoimmune thyroiditis. Methods Mol Med. 102:175–193.
2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang WK, Wang B, Lu QH, Zhang W, Qin WD,
Liu XJ, Liu XQ, An FS, Zhang Y and Zhang MX: Inhibition of
high-mobility group box 1 improves myocardial fibrosis and
dysfunction in diabetic cardiomyopathy. Int J Cardiol. 172:202–212.
2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wehr MC, Hinrichs W, Brzozka MM,
Unterbarnscheidt T, Herholt A, Wintgens JP, Papiol S,
Soto-Bernardini MC, Kravchenko M, Zhang M, et al: Spironolactone is
an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant
endophenotypes in mice. EMBO Mol Med. 9:1448–1462. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Perera P, Lobo V, Williams SR and
Gharahbaghian L: Cardiac echocardiography. Crit Care Clin.
30:47–92, v. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pan XC, Li ZX, Wu DZ, Li SY, Xiang HB and
Song YT: Mapping changes of whole brain blood flow in rats with
myocardial ischemia/reperfusion injury assessed by positron
emission tomography. Curr Med Sci. 39:653–657. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rudski LG, Lai WW, Afilalo J, Hua L,
Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK and
Schiller NB: Guidelines for the echocardiographic assessment of the
right heart in adults: A report from the American Society of
Echocardiography endorsed by the European Association of
Echocardiography, a registered branch of the European Society of
Cardiology, and the Canadian Society of Echocardiography. J Am Soc
Echocardiogr. 23:685–713; quiz 786-8. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Weber KT: Aldosterone in congestive heart
failure. N Engl J Med. 345:1689–1697. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tschope C, Ammirati E, Bozkurt B, Caforio
ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Hubner
N, et al: Myocarditis and inflammatory cardiomyopathy: Current
evidence and future directions. Nat Rev Cardiol. 18:169–193.
2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Trojanowska M: Ets factors and regulation
of the extracellular matrix. Oncogene. 19:6464–6471.
2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hanna A, Humeres C and Frangogiannis NG:
The role of Smad signaling cascades in cardiac fibrosis. Cell
Signal. 77(109826)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yancy CW, Jessup M, Bozkurt B, Butler J,
Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC,
Givertz MM, et al: 2017 ACC/AHA/HFSA Focused Update of the 2013
ACCF/AHA Guideline for the management of heart failure: A report of
the American college of cardiology/American heart association task
force on clinical practice guidelines and the heart failure society
of America. Circulation. 136:e137–e161. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Iwasaka C, Tanaka K, Abe M and Sato Y:
Ets-1 regulates angiogenesis by inducing the expression of
urokinase-type plasminogen activator and matrix metalloproteinase-1
and the migration of vascular endothelial cells. J Cell Physiol.
169:522–531. 1996.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kukacka J, Prusa R, Kotaska K and Pelouch
V: Matrix metalloproteinases and their function in myocardium.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 149:225–236.
2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Staudt A, Staudt Y, Dorr M, Bohm M, Knebel
F, Hummel A, Wunderle L, Tiburcy M, Wernecke KD, Baumann G and
Felix SB: Potential role of humoral immunity in cardiac dysfunction
of patients suffering from dilated cardiomyopathy. J Am Coll
Cardiol. 44:829–836. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Keidar S, Kaplan M, Pavlotzky E, Coleman
R, Hayek T, Hamoud S and Aviram M: Aldosterone administration to
mice stimulates macrophage NADPH oxidase and increases
atherosclerosis development: A possible role for
angiotensin-converting enzyme and the receptors for angiotensin II
and aldosterone. Circulation. 109:2213–2220. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hu LJ, Chen YQ, Deng SB, Du JL and She Q:
Additional use of an aldosterone antagonist in patients with mild
to moderate chronic heart failure: A systematic review and
meta-analysis. Br J Clin Pharmacol. 75:1202–1212. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tsutamoto T: Mineralocorticoid receptor
antagonist spironolactone improves left ventricular remodeling in
patients with congestive heart failure and acute myocardial
infarction. Nihon Yakurigaku Zasshi. 124:90–100. 2004.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
30
|
Liu X, Zhang X, Ye L and Yuan H:
Protective mechanisms of berberine against experimental autoimmune
myocarditis in a rat model. Biomed Pharmacother. 79:222–230.
2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li J, Schwimmbeck PL, Tschope C, Leschka
S, Husmann L, Rutschow S, Reichenbach F, Noutsias M, Kobalz U,
Poller W, et al: Collagen degradation in a murine myocarditis
model: Relevance of matrix metalloproteinase in association with
inflammatory induction. Cardiovasc Res. 56:235–247. 2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li YY, Kadokami T, Wang P, McTiernan CF
and Feldman AM: MMP inhibition modulates TNF-alpha transgenic mouse
phenotype early in the development of heart failure. Am J Physiol
Heart Circ Physiol. 282:H983–H989. 2002.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Huber SA, Polgar J, Schultheiss P and
Schwimmbeck P: Augmentation of pathogenesis of coxsackievirus B3
infections in mice by exogenous administration of interleukin-1 and
interleukin-2. J Virol. 68:195–206. 1994.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cleland JGF, Ferreira JP, Mariottoni B,
Pellicori P, Cuthbert J, Verdonschot JAJ, Petutschnigg J, Ahmed FZ,
Cosmi F, Brunner La Rocca HP, et al: The effect of spironolactone
on cardiovascular function and markers of fibrosis in people at
increased risk of developing heart failure: The heart ‘OMics’ in
AGEing (HOMAGE) randomized clinical trial. Eur Heart J. 42:684–696.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Brilla CG and Weber KT: Reactive and
reparative myocardial fibrosis in arterial hypertension in the rat.
Cardiovasc Res. 26:671–677. 1992.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu W, Gong W, He M, Liu Y, Yang Y, Wang
M, Wu M, Guo S, Yu Y, Wang X, et al: Spironolactone protects
against diabetic cardiomyopathy in streptozotocin-induced diabetic
rats. J Diabetes Res. 2018(9232065)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Okuducu AF, Zils U, Michaelis SA,
Michaelides S and von Deimling A: Ets-1 is up-regulated together
with its target gene products matrix metalloproteinase-2 and matrix
metalloproteinase-9 in atypical and anaplastic meningiomas.
Histopathology. 48:836–845. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hahne JC, Okuducu AF, Fuchs T, Florin A
and Wernert N: Identification of ETS-1 target genes in human
fibroblasts. Int J Oncol. 38:1645–1652. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hori Y, Kashimoto T, Yonezawa T, Sano N,
Saitoh R, Igarashi S, Chikazawa S, Kanai K, Hoshi F, Itoh N and
Higuchi S: Matrix metalloproteinase-2 stimulates collagen-I
expression through phosphorylation of focal adhesion kinase in rat
cardiac fibroblasts. Am J Physiol Cell Physiol. 303:C947–C953.
2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Li Y, Ma J, Zhu H, Singh M, Hill D, Greer
PA, Arnold JM, Abel ED and Peng T: Targeted inhibition of calpain
reduces myocardial hypertrophy and fibrosis in mouse models of type
1 diabetes. Diabetes. 60:2985–2994. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhao N, Zou H, Qin J, Fan C, Liu Y, Wang
S, Shan Z, Teng W and Li Y: MicroRNA-326 contributes to autoimmune
thyroiditis by targeting the Ets-1 protein. Endocrine. 59:120–129.
2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Xu L, Fu M, Chen D, Han W, Ostrowski MC,
Grossfeld P, Gao P and Ye M: Endothelial-specific deletion of Ets-1
attenuates Angiotensin II-induced cardiac fibrosis via suppression
of endothelial-to-mesenchymal transition. BMB Rep. 52:595–600.
2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Steinl DC, Xu L, Ochoa-Espinosa A, Punjabi
M and Kaufmann BA: Non-invasive contrast enhanced ultrasound
molecular imaging of inflammation in autoimmune myocarditis for
prediction of left ventricular fibrosis and remodeling. PLoS One.
14(e0224377)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Hu HH, Chen DQ, Wang YN, Feng YL, Cao G,
Vaziri ND and Zhao YY: New insights into TGF-beta/Smad signaling in
tissue fibrosis. Chem Biol Interact. 292:76–83. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Yue Y, Meng K, Pu Y and Zhang X:
Transforming growth factor beta (TGF-β) mediates cardiac fibrosis
and induces diabetic cardiomyopathy. Diabetes Res Clin Pract.
133:124–130. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Duivenvoorden WC, Hirte HW and Singh G:
Transforming growth factor beta1 acts as an inducer of matrix
metalloproteinase expression and activity in human
bone-metastasizing cancer cells. Clin Exp Metastasis. 17:27–34.
1999.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Okano K, Hibi A, Miyaoka T, Inoue T,
Sugimoto H, Tsuchiya K, Akiba T and Nitta K: Inhibitory effects of
the transcription factor Ets-1 on the expression of type I collagen
in TGF-beta1-stimulated renal epithelial cells. Mol Cell Biochem.
369:247–254. 2012.PubMed/NCBI View Article : Google Scholar
|
